Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Mu Opioid Receptor 1 Antikörper:
anti-Mouse (Murine) Mu Opioid Receptor 1 Antikörper:
anti-Rat (Rattus) Mu Opioid Receptor 1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Cat (Feline) Polyclonal Mu Opioid Receptor 1 Primary Antibody für IEM, ICC - ABIN617908
Gracy, Svingos, Pickel: Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. in The Journal of neuroscience : the official journal of the Society for Neuroscience 1997
Show all 127 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody für IHC - ABIN966719
Wang, Johnson, Persico, Hawkins, Griffin, Uhl: Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. in FEBS letters 1994
Show all 7 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody für IF (p), IHC (p) - ABIN701755
Laureano, Dalle Molle, Alves, Luft, Desai, Ross, Silveira: Intrauterine growth restriction modifies the hedonic response to sweet taste in newborn pups - Role of the accumbal μ-opioid receptors. in Neuroscience 2016
Show all 2 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody für IF (p), IHC (p) - ABIN703210
Brewer, Baran, Whitfield, Jensen, Clemens: Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord. in Frontiers in neural circuits 2014
Show all 2 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody für IHC, IHC (p) - ABIN441215
Dever, Xu, Fitting, Knapp, Hauser: Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types. in Journal of neurovirology 2012
Show all 2 Pubmed References
Polyclonal Mu Opioid Receptor 1 Primary Antibody für WB - ABIN4948303
Rodríguez-Muñoz, de la Torre-Madrid, Gaitán, Sánchez-Blázquez, Garzón: RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. in Cellular signalling 2007
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody für ICC, IHC (fro) - ABIN250447
Vassoler, Wright, Byrnes: Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring. in Neuropharmacology 2016
In summary, our results suggest that, by genetic association, the mu-opioid receptor interacts with serotonin transporter (zeige SLC6A4 Antikörper) and serotonin 1A receptor to modulate exercise-induced hypoalgesia in fibromyalgia.
Significant epistatic interactions were determined between OPRM1 and DAT1 genotypes on alcohol consumption and subjective effects in social drinkers.
OPRM1/mu-opioid receptor system was uniformly expressed by epidermal keratinocytes from psoriasis patients and controls.
Morphine-induced MOP receptor endocytosis is facilitated by concurrent M3 activation.M3 and MOP (zeige NLN Antikörper) assemble in receptor heterocomplexes mainly located at the plasma membrane.M3-MOP receptor pharmacological interaction is independent of heterocomplex formation.M3 and MOP receptor heteromers disrupt upon both receptor endocytosis.
A quantitative trait loci in OPRM1 is associated with alcohol use phenotypes and the subjective response to alcohol.
ADRB2 (zeige ADRB2 Antikörper) gene expressed in HIV-associated neurocognitive impairment and encephalitis chaperones OPRM1, normally located intracellularly in astrocytes, to the cell surface.
These results are in line with previous studies suggesting that mu-opioid receptor signalling has been elaborated beyond its basic function of pain modulation to play an important role in managing our social encounters.
Significant interaction of OPRM1 genotype, binding potential for [(11)C]carfentanil in the ventral striatum, and relapse risk in alcoholics.
Functional activity of Dynorphin 1-17 and fragments (1-6, 1-7 and 1-9) were screened over a range of concentrations against forskolin stimulated human embryonic kidney 293 (HEK (zeige EPHA3 Antikörper)) cells stably transfected with one of KOP (zeige SPINT2 Antikörper), MOP (zeige NLN Antikörper) or DOP (zeige COPB2 Antikörper)
In utero exposure to opioids is associated with increased DNA methylation (zeige HELLS Antikörper) of ABCB1 (zeige ABCB1 Antikörper), CYP2D6 (zeige CYP2D6 Antikörper), and OPRM1 opioid-related genes in the newborn infant.
The CeA (zeige CEA Antikörper) was subsequently targeted with bilateral infusions of the MOR antagonist naloxonazine, which significantly reduced sodium appetite in mice. The CeA (zeige CEA Antikörper) is therefore identified as a key node in the circuit that contributes to sodium appetite. Moreover, endogenous opioids, acting via MOR, within the CeA (zeige CEA Antikörper) promote this form of appetitive behavior
Oprm1 knock-out mice lacking 6TM genetic variants failed to show morphine-induced hyperalgesia.
Findings implicate truncated Oprm1 6TM splice variants in analgesic mechanisms and suggest that they may help explain many of the subtle, but important, clinical differences among mu opioids.
The data show that somatic MORs in POMC (zeige POMC Antikörper) neurons couple to multiple effectors that have differential sensitivity to desensitization of the receptor.
C termini generated from 3' alternative splicing of the mu opioid receptor gene are pharmacologically distinct.
Double mothering normalized the abnormal response to maternal separation in Oprm1-knockout mice, in an animal model of Autism.
OPRM1, expressed by primary afferent nociceptors, initiates opiate tolerance and opioid-induced hyperalgesia development.
Study reveals dissociable Mu opioid receptors (MOR) functions across mesocorticolimbic networks. Beyond a role in reward processing, operating at the level of local ventral tegmental area neurons, MORs also moderate motivation for appetitive stimuli within forebrain circuits that drive motivated behaviors.
MOR-T394 mutation or polymorphisms could be a risk factor in developing opioid abuse and addiction and therefore be used as a new biomarker in prediction and prevention of opioid abuse and addiction
MOR epigenetic regulation requires multiple coordinated signals converging at the MOR promoter, involving mitogen-activated protein kinase (zeige MAPK1 Antikörper) (MAPK (zeige MAPK1 Antikörper)) activation and mitogen- and stress-activated protein kinase 1 (zeige RPS6KA5 Antikörper).
MicroRNA miR (zeige MYLIP Antikörper)-212/132 cluster is actively repressing the expression of mu opioid receptor (Oprm1) by targeting a sequence in the 3' UTR (zeige UTS2R Antikörper) of its mRNA.
demonstrate that zfMOR exhibits a pharmacological profile similar to that of the mammalian MOR.
Coactivation of mu opioid receptors with nociceptin (zeige PNOC Antikörper) receptors produces synergistic antinociception.
Thisstudy adds to the growing literature showing that variation in the mu-opioid receptor gene OPRM1 is associated with social attachment and rejection.
OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors.
findings suggest a role for OPRM1 variation in the expression of attachment behavior, especially as a function of separation from the caregiver
This gene encodes one of three opioid receptors. The mu opioid receptor is the principal target of endogenous opioid peptides and opioid analgesic agents such a s beta-endorphn and enkephalins. The NM_001008503.1:c.118A>G allele had been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene.
micro opioid receptor isoform hMOR-1A2
, mu opiate receptor
, mu opioid receptor hMOR-1a
, mu-type opioid receptor
, MOP receptor
, mu opioid receptor splice variant rMOR-1S
, mu opioid receptor splice variant rMOR-1Z
, opioid receptor B
, opioid receptor, mu 1
, mu opioid receptor
, mu-opioid receptor
, outer membrane protein OprM